111 related articles for article (PubMed ID: 6284580)
1. [Should one treat with systemic adriamycin inoperable hepatocellular cancer in cirrhosis?].
Ballet F; Barbare JC; Petit J; Poupon R; Darnis F
Gastroenterol Clin Biol; 1982 Mar; 6(3):267-71. PubMed ID: 6284580
[No Abstract] [Full Text] [Related]
2. [Hepatocellular carcinoma with cirrhosis: treatment with doxorubicin. Phase II evaluation].
Barbare JC; Ballet F; Petit J; Poupon R; Darnis F
Bull Cancer; 1984; 71(5):442-5. PubMed ID: 6084528
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of adriamycin in hepatoma patients with cirrhosis.
Chan KK; Chlebowski RT; Tong M; Chen HS; Gross JF; Bateman JR
Cancer Res; 1980 Apr; 40(4):1263-8. PubMed ID: 6244090
[No Abstract] [Full Text] [Related]
4. Adriamycin therapy in American patients with hepatocellular carcinoma.
Ihde DC; Kane RC; Cohen MH; McIntire KR; Minna JD
Cancer Treat Rep; 1977 Oct; 61(7):1385-7. PubMed ID: 201380
[No Abstract] [Full Text] [Related]
5. Trial of adriamycin in primary hepatocellular carcinoma.
Tsega E
Ethiop Med J; 1984 Jan; 22(1):55-9. PubMed ID: 6317377
[No Abstract] [Full Text] [Related]
6. [Advanced hepatocellular carcinoma: value of systemic chemotherapy combining adriamycin, amiodarone and 5-fluorouracil].
Bedenne L; Chauffert B; Lorcerie B; Faivre J; Hillon P; Klepping C; Martin F
Gastroenterol Clin Biol; 1989 Oct; 13(10):845-6. PubMed ID: 2556316
[No Abstract] [Full Text] [Related]
7. [Treatment of hepatocellular carcinoma with adriamycin. Phase II clinical trial].
Barbare JC; Ballet F; Petit J; Poupon R; Darnis F
Gastroenterol Clin Biol; 1984; 8(8-9):679-80. PubMed ID: 6092187
[No Abstract] [Full Text] [Related]
8. Treatment of primary liver cancer: response to regional chemotherapy.
Wellwood JM; Cady B; Oberfield RA
Clin Oncol; 1979 Mar; 5(1):25-31. PubMed ID: 217565
[No Abstract] [Full Text] [Related]
9. [Evaluation of chemotherapy in hepatocellular carcinoma with liver cirrhosis].
Munehisa T; Tajima H; Goto M; Nakata K; Muro T; Kawahara K; Kohno K; Sato A; Furukawa R; Ogino T
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2318-23. PubMed ID: 6314913
[TBL] [Abstract][Full Text] [Related]
10. Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.
Baker LH; Saiki JH; Jones SE; Hewlett JS; Brownlee RW; Stephens RL; Vaitkevicius VK
Cancer Treat Rep; 1977 Nov; 61(8):1595-7. PubMed ID: 200359
[No Abstract] [Full Text] [Related]
11. Clinical studies in Asian patients with irresectible primary hepatocellular carcinoma treated by adriamycin and prednisolone alone or in combination with 5-fluorouracil, vincristine and prednisolone.
Singapore Med J; 1978 Dec; 19(4):192-204. PubMed ID: 220733
[No Abstract] [Full Text] [Related]
12. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.
Pinter M; Sieghart W; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Plank C; Peck-Radosavljevic M
Oncologist; 2009 Jan; 14(1):70-6. PubMed ID: 19144684
[TBL] [Abstract][Full Text] [Related]
13. Diamminodichloride platinum (cis-platinum) in the treatment of hepatocellular carcinoma.
Melia WM; Westaby D; Williams R
Clin Oncol; 1981 Dec; 7(4):275-80. PubMed ID: 6172230
[No Abstract] [Full Text] [Related]
14. Cardiac cirrhosis and hepatocellular carcinoma in a 13-year-old treated with doxorubicin microbead transarterial chemoembolization.
Rosenbaum J; Vrazas J; Lane GK; Hardikar W
J Paediatr Child Health; 2012 Mar; 48(3):E140-3. PubMed ID: 21199060
[TBL] [Abstract][Full Text] [Related]
15. [A case of advanced hepatocellular carcinoma with lung metastases and cirrhosis that responded to combination chemotherapy with interferon-alpha and 5-fluorouracil].
Shitara K; Munakata M; Kudo T; Muto O; Okada R; Mitobe S; Sakata Y; Kondo M; Ishii E; Yabu K
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2083-6. PubMed ID: 17197759
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
Wen J; Shen WL; Yang SH
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
[TBL] [Abstract][Full Text] [Related]
17. Phase I clinical trial of liposomal daunorubicin in hepatocellular carcinoma complicating liver cirrhosis.
Daniele B; De Vivo R; Perrone F; Lastoria S; Tambaro R; Izzo F; Fiore F; Vallone P; Pignata S
Anticancer Res; 2000; 20(2B):1249-51. PubMed ID: 10810429
[TBL] [Abstract][Full Text] [Related]
18. [Liver resection after downstaging with systemic chemotherapy in a case of a multicentric hepatocellular carcinoma with virus B cirrhosis].
Ionescu M; Dumitraşcu T; Stroescu C
Chirurgia (Bucur); 2007; 102(3):337-43. PubMed ID: 17687865
[TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of doxorubicin plus amiodarone in advanced hepatocarcinoma.
Chauffert B; Seitz JF; Bedenne L; Renard P; Conroy T; Rougier P
Gastroenterol Clin Biol; 1991; 15(10):774-5. PubMed ID: 1667769
[No Abstract] [Full Text] [Related]
20. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
Mun BS; Ahn HS; Ahn DS; Lee SO
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
